ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,127.79
      1.26%
      US Tech 100
      17,446.00
      2.17%
      Dow Jones
      38,675.68
      1.18%
      Brent Oil
      82.765
      0.00%
      Bitcoin
      63,924.67
      1.65%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Biolase Inc (BIOL)

      7. Biolase Inc (BIOL) News

      BIOL

      Biolase (BIOL)

      Biolase Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:BIOL
      DateTimeSourceHeadlineSymbolCompany
      03/08/20246:31AMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:BIOLBiolase Inc
      03/05/20246:05AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
      02/27/20244:14PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
      02/23/20244:05PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BIOLBiolase Inc
      02/21/20244:39PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BIOLBiolase Inc
      02/21/20247:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
      02/15/20245:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
      02/14/20241:10PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BIOLBiolase Inc
      02/14/202412:15AMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BIOLBiolase Inc
      02/13/20248:03PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BIOLBiolase Inc
      02/09/20248:44AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BIOLBiolase Inc
      02/07/20246:11AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BIOLBiolase Inc
      02/07/20246:04AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
      01/30/20249:57PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BIOLBiolase Inc
      01/29/20245:01PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
      01/29/20246:30AMPR Newswire (US)BIOLASE REPORTS UNAUDITED REVENUE GROWTH FOR FULL YEAR 2023 AND PROVIDES OUTLOOK FOR FULL YEAR 2024NASDAQ:BIOLBiolase Inc
      01/24/20245:21PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BIOLBiolase Inc
      01/19/20246:09AMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BIOLBiolase Inc
      01/08/20244:05PMPR Newswire (US)BIOLASE ENHANCES EDUCATION OFFERINGS IN 2024 DUE TO INCREASING DEMAND OF DENTAL LASER COURSES THROUGHOUT 2023NASDAQ:BIOLBiolase Inc
      01/03/20244:05PMPR Newswire (US)BIOLASE RECEIVES SECOND TOP WORKPLACES 2023 AWARDNASDAQ:BIOLBiolase Inc
      12/29/20234:05PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
      12/26/20235:22PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BIOLBiolase Inc
      12/20/20232:13PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:BIOLBiolase Inc
      12/14/20234:05PMPR Newswire (US)BIOLASE RECEIVES TOP WORKPLACES 2023 AWARDNASDAQ:BIOLBiolase Inc
      12/12/20234:05PMPR Newswire (US)BIOLASE Successfully Concludes Waterlase iPlus All Tissue Laser TrialNASDAQ:BIOLBiolase Inc
      12/08/20239:25AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
      12/08/20239:23AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:BIOLBiolase Inc
      12/06/20231:46PMPR Newswire (US)BIOLASE, Inc. Announces Pricing of $1.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:BIOLBiolase Inc
      11/17/20234:17PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:BIOLBiolase Inc
      11/09/20234:52PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:BIOLBiolase Inc
       Showing the most relevant articles for your search:NASDAQ:BIOL